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Previous studies have shown that the cell cycle-regulated E2F transcription factor is subjected to both positive and
negative control by phosphorylation. Here we show that in transient transfection experiments, adenovirus E1A activation of
the viral E2 promoter is abrogated by coexpression of the viral E4 open reading frame 4 (E4-ORF4) protein. This effect does
not to require the retinoblastoma protein that previously has been shown to regulate E2F activity. The inhibitory activity of
E4-ORF4 appears to be specific because E4-ORF4 had little effect on, for example, E4-ORF6/7 transactivation of the E2
promoter. We further show that the repressive effect of E4-ORF4 on E2 transcription works mainly through the E2F
DNA-binding sites in the E2 promoter. In agreement with this, we find that E4-ORF4 inhibits E2F-1/DP-1-mediated transac-
tivation. We also show that E4-ORF4 inhibits E2 mRNA expression during virus growth. E4-ORF4 has previously been shown
to bind to and activate the cellular protein phosphatase 2A. The inhibitory effect of E4-ORF4 was relieved by okadaic acid,
which inhibits protein phosphatase 2A activity, suggesting that E4-ORF4 represses E2 transcription by inducing transcription
factor dephosphorylation. Interestingly, E4-ORF4 did not inhibit the transactivation capacity of a Gal4-E2F hybrid protein.
Instead, E4-ORF4 expression appears to result in reduced stability of E2F/DNA complexes. © 1999 Academic Press
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The E2F family of transcription factors are important
egulators of the cell cycle, controlling the transcription
f genes needed for DNA synthesis (reviewed in La
hangue, 1994). They form heterodimeric complexes
onsisting of one of six E2F proteins (E2F-1–6) and one
f two DP proteins (DP-1 or -2) (reviewed in Dyson, 1998).
he activity of these complexes, here collectively re-
erred to as E2F, is controlled by several mechanisms.
irst, binding of the retinoblastoma tumor suppressor
rotein (pRB) and its relatives p107 and p130 to E2F
ranscription factors results in active repression of tran-
cription (reviewed in Dynlacht, 1997). The pRB/E2F as-
ociation is cell cycle regulated and controlled by cyclin-
ependent kinases such that pRB phosphorylation dis-
ociates the inhibitory complex, resulting in a release of
ctive E2F (reviewed in Weinberg, 1995) Second, the
ctivity of E2F is directly controlled by phosphorylation.
yclin A and its associated kinase bind to E2F-1 and
hosphorylates its partner DP-1, which results in loss of
NA binding (Dynlacht et al., 1994; Krek et al., 1994)
hird, the stability of E2F proteins is controlled by ubiq-
itin-dependent protein degradation, which is prevented
y pRB and adenovirus E1A and E1B proteins (Campan-
1 To whom reprint requests should be addressed. Fax: 46-18-509876.
p-mail: goran.akusjarvi@imim.uu.se.
313ro and Flemington, 1997; Hateboer et al., 1996; Hofmann
t al., 1996).
Adenovirus has been a valuable tool in elucidating the
unctions of E2F proteins (Nevins, 1992). E2F was first
dentified as a transcription factor required for adenovi-
us E2 promoter activity (Kovesdi et al., 1986b). The
ctivity of the E2 promoter increases during virus infec-
ion concomitant with an increased binding of E2F to the
2 promoter (Kovesdi et al., 1986a; Reichel et al., 1988).
ncreased E2F activity can be attributed to several virus-
nduced changes. Adenovirus E1A binds to pRB (Whyte
t al., 1988), thereby dissociating the inhibitory pRB/E2F
omplex. However, E1A also activates transcription by
lternative mechanisms (reviewed in Akusja¨rvi, 1993).
hus evidence has been published suggesting that E1A
ight induce phosphorylation of E2F, resulting in in-
reased binding of E2F to the E2 promoter (Bagchi et al.,
989). Also, adenovirus encodes the E4-ORF6/7 protein
hat binds to E2F and induces cooperative binding of E2F
ranscription factors to the two inverted E2F binding sites
n the viral E2 promoter (reviewed in Lam and La
hangue, 1994).
To address the role of phosphorylation in E1A trans-
ctivation, we investigated the effect of the adenovirus
4-ORF4 protein on E2 promoter activity and E2F-1-me-
iated transactivation. This viral protein binds to and
ctivates the serine- and threonine-specific protein
hosphatase 2A (PP2A) (Kleinberger and Shenk, 1993).
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314 MANNERVIK ET AL.e have previously shown that the E4-ORF4 protein
nhibits E1A activation of the adenovirus E4 promoter
hrough PP2A (Bondesson et al., 1996). Here we extend
hese studies and show that E4-ORF4 regulates E2F
ransactivation of the viral E2 promoter in transient trans-
ection experiments and E2 mRNA expression during
irus growth. To be able to study E1A and E2F phospho-
ylation-dependent activation independently of E2F–pRB
ssociation, the transient transfection experiments were
erformed in HeLa cells, which express the human pap-
lloma virus (HPV) E7 protein that binds and inactivates
RB (Dyson et al., 1989), and in SAOS-2 cells that do not
xpress a functional pRB (Shew et al., 1990). We found
hat efficient E1A activation of the E2 promoter requires
2F binding sites in the E2 promoter and further show
hat the E4-ORF4-PP2A protein complex inhibits E1A
ctivation of the E2 promoter as well as E2F-1/DP-1-
ediated transactivation through PP2A. However, E4-
RF4 does not affect the transactivation capacity of
2F-1. Mechanistically, E4-ORF4 appears to destabilize
2F/DNA interaction.
RESULTS
he adenovirus E4-ORF4 protein inhibits E1A but not
4-ORF6/7 transactivation of the E2 promoter
We have previously shown that the E4-ORF4-PP2A
omplex prevents E1A activation of the E4 promoter
Bondesson et al., 1996). Because the E2 promoter sim-
larly has been suggested to be regulated through E1A-
nduced phosphorylation of E2F (Bagchi et al., 1989), we
ested the effect of the viral E4-ORF4 protein on E2
romoter activity in HeLa cells. As shown in Fig. 1,
4-ORF4 had a small stimulatory effect on E2 promoter
ctivity in the absence of E1A (lanes 1 and 2). In contrast,
4-ORF4 coexpression resulted in a significant inhibition
f E1A transactivation of the E2 promoter (lanes 3 and 4).
hese observations are in line with the hypothesis that
2F phosphorylation can have both a negative and a
ositive effect on E2F activity (see Discussion). Impor-
antly, E4-ORF4 coexpression did not affect the level of
1A protein expression (Bondesson et al., 1996; and data
ot shown). Treatment of the cells with okadaic acid,
hich inhibits PP2A, annulled the repressive effect of
4-ORF4 on E1A transactivation (lanes 4 and 5), suggest-
ng that the effect of E4-ORF4 requires recruitment of
P2A.
The E4-ORF6/7 protein binds to E2F/DP heterodimers
nd stabilizes binding to the inverted E2F-binding sites
resent in the E2 promoter. Figure 1, lanes 6 and 7,
hows that in contrast to E1A-mediated activation, E4-
RF4 had little effect on E4-ORF6/7 transactivation. We
onclude that the effect of E4-ORF4 is selective in that it
ramatically inhibits E1A activation of the E2 promoter
hile only modestly affecting the E2 transactivation ca-
acity of the E4-ORF6/7 protein. a4-ORF4 works through the E2F-binding sites in the
2 promoter
The adenovirus E2 promoter consists of a single ATF-
inding site and two inverted E2F-binding sites (see Fig.
). To determine which factor mediates E1A induction
nd E4-ORF4 inhibition of E2 transcription, we compared
he E2(2ATF)CAT and E2(2E2F)CAT promoter deriva-
ives, that lack the ATF or E2F sites, respectively. As
hown in Fig. 2, E2(2ATF)CAT was efficiently activated
y E1A, a stimulation that was inhibited by E4-ORF4
oexpression. Okadaic acid treatment of transfected
ells abolished completely the inhibitory effect of E4-
RF4 on E1A transactivation of E2(2ATF)CAT. In con-
rast, E2(2E2F)CAT did not respond significantly to either
1A or E4-ORF4 expression. Thus in HeLa cells, the E2
romoter is activated by E1A mainly through the E2F-
inding sites, which also are major targets of the E4-
RF4 protein.
2F-1/DP-1 transactivation is inhibited by E4-ORF4
The results obtained with E2(2ATF)CAT suggested
hat E2F is the primary target of E1A activation. We
herefore determined the effect of E1A on an E2F4CAT
eporter plasmid containing four tandem E2F binding
ites. As shown in Fig. 3A, E1A activation of this reporter
as modest, only ;4-fold (lanes 1 and 2). Cotransfection
f E2F-1 and DP-1 efficiently activated E2F4CAT (lanes 1
FIG. 1. The adenovirus E4-ORF4 protein inhibits E1A but not E4-
RF6/7 transactivation of the E2 promoter. The E2CAT reporter plasmid
bottom) was cotransfected together with an E4-ORF4 expressing plas-
id (1) or the CMV promoter backbone plasmid (2) into HeLa cells.
here indicated, a wild-type E1A expression plasmid or an E4-ORF6/7
xpression plasmid was included. In lane 6, 100 nM okadaic acid was
dded to the growth medium approximately 12 h before harvest. Shown
s a representative CAT assay and the mean values calculated form at
east three independent experiments with the standard deviations
hown within brackets.nd 3), but inclusion of E1A resulted in a minor stimula-
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315Ad E4-ORF4 REGULATES E2F TRANSACTIVATIONory effect on transcription (lanes 3 and 4). The effect of
1A expression on E2F4CAT contrasts sharply with that
f E2(2ATF)CAT, which is activated ;12-fold by E1A (Fig.
). These results might be related to the fact that the
2F-binding sites in the E2 promoter are inverted (Fig. 1),
hereas they are parallel in the E2F4CAT reporter (Fig.
A). Thus the organization of E2F sites in the promoter
ay be crucial for E1A transactivation.
Although E4-ORF4 did not repress basal E2 promoter
ctivity (Fig. 1, lanes 1 and 2), it greatly impaired the
bility of E2F-1/DP-1 to activate E2F4CAT (Fig. 3B, lanes
and 4), without affecting the levels of E2F-1 protein
xpression (data not shown). Treatment of the cells with
kadaic acid stimulated E2F-1/DP-1 transactivation by
-fold (Fig. 3B, lanes 2 and 3). Cotransfection of E4-ORF4,
hich activates PP2A dephosphorylation of target pro-
eins, resulted in a 5-fold reduction in E2F4CAT activity
Fig. 3B; lanes 2 and 4). Inclusion of okadaic acid not only
nnulled the inhibitory activity of E4-ORF4 but also stim-
lated E2F4CAT expression (Fig. 3B; lanes 4 and 5),
uggesting that the effect of E4-ORF4 is due to its re-
ruitment of PP2A. Collectively, these results suggest
hat phosphorylation is important for E2F function. Thus
he addition of okadaic acid results in a stimulation of
2F4CAT expression due to inhibition of phosphatases
n the cell. In this model, E4-ORF4 cotransfection results
n an increased recruitment of PP2A and thus a dramatic
eduction in E2FCAT expression. We conclude that the
ransactivation capacity of E2F-1 is dependent on phos-
horylation, an activity that can be regulated by the
4-ORF4 protein.
al4-E2F-1 transactivation is refractory to E4-ORF4
nhibition
To determine whether E4-ORF4 works by inactivating
FIG. 2. E1A activation and E4-ORF4 inhibition of E2 transcription
2(2ATF)CAT and E2(2E2F)CAT, lacking the ATF or E2F sites, respe
ogether with the E4-ORF4 expression plasmid (1) or the empty CMV p
as included when so indicated. OA indicates that okadaic acid was ad
re shown with quantifications based on three independent experimenhe transactivation domain of E2F-1, a fusion protein cetween the Gal4 DNA-binding domain and E2F-1 (Gal4-
2F-1) was transfected together with the G5E1BCAT re-
orter plasmid containing five Gal4-binding sites (Fig. 4).
n agreement with our previous results (Bondesson et al.,
996), E4-ORF4 inhibited Gal4-E1A CR3 transactivation in
his type of assay (lanes 1 and 2). In contrast, Gal4-E2F-
-dependent transactivation was unaffected by E4-ORF4
oexpression (lanes 3 and 4). Thus we conclude that the
epressive effect of E4-ORF4 on E2F-dependent tran-
cription does not occur through inactivation of the trans-
ctivation capacity of the E2F-1 activation domain.
4-ORF4 destabilizes the DNA-binding capacity of
2F-1/DP-1 heterodimers
Because the transactivation capacity of the E2F-1 ef-
ector domain was unaffected by E4-ORF4, we tested the
NA-binding ability of E2F-1/DP-1 in the presence of
4-ORF4 by gel-shift analysis. As shown in Fig. 5A, al-
ost no specific E2F-binding complexes with a single
2F site probe were observed in mock transfected cells
lane 1). Transfection of E2F-1/DP-1 resulted in a major
omplex and a minor more slowly migrating complex
lane 2). Because the majority of pRB is expected to be
nactivated in HeLa cells (Dyson et al., 1989), the major
omplex most likely represent free E2F. Both complexes
ere supershifted with an E2F-1-specific antibody (lane
) or an anti-HA tag antibody recognizing DP-1 (lane 4)
ut not by normal rabbit serum (lane 5). The complexes
ere refractory to the inclusion of a 100-fold excess of
utant competitor oligonucleotide (lane 6) but almost
ompletely abolished by wild-type competitor (lane 7).
mportantly, neither E4-ORF4 (lane 8) nor E1A (lane 9)
otransfection affected the DNA-binding capacity of E2F-
/DP-1 in this type of binding assay.
We therefore compared the stability of the E2F-DNA
s the E2F binding sites in the E2 promoter. The reporter plasmids
(schematically shown at the bottom of the figure), were transfected
r control plasmid (2) into HeLa cells. An E1A-expressing plasmid (1)
the growth medium ;12 h before harvest. Representative CAT assays
h the standard deviations within brackets.require
ctively
romote
ded toomplexes in the absence and presence of E4-ORF4. For
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316 MANNERVIK ET AL.his experiment, we preincubated extracts prepared from
2F-1/DP-1 or E2F-1/DP-1 1 E4-ORF4 cotransfected
ells with the E2F probe for 15 min and then included
ild-type competitor oligonucleotide for increasing
mounts of time. As shown in Fig. 5B, the dissociation
ate of E2F-1/DP-1 from DNA increased ;2-fold in the
resence of E4-ORF4. Thus it is possible that the repres-
ive effect of E4-ORF4 on E2F-1/DP-1 transactivation in
ur assay system (Fig. 3A) results, at least in part, from a
educed stability of E2F binding to DNA.
nhibition of E2F transactivation by E4-ORF4 occurs
n the absence of pRB
All experiments thus far were performed in HeLa cells,
hich are believed to contain inactivated pRB, due to the
FIG. 3. E4-ORF4 inhibits E2F-1/DP-1-mediated transactivation. HeLa
ells were transfected with the E2F4CAT reporter plasmid in the ab-
ence or presence of E2F-1 and DP-1 expression plasmids. Inclusion of
4-ORF4 is indicated by a plus sign. In all transfections, an empty CMV
romoter control plasmid was included to give equal amount of CMV
romoter-containing plasmids. (A) E1A-expressing plasmid (pML005)
r the pMLDE1A control plasmid (lanes 1 and 3) was additionally
ncluded. (B) In lanes 3 and 5, okadaic acid was added to the growth
edium ;12 h before harvest. (Bottom) Schematic of the E2F4CAT
eporter plasmid. n.d., not detectable. Representative CAT assays and
uantifications based on at least three independent experiments areHhown, with the standard deviations within brackets.xpression of the integrated HPV-E7 gene product
Dyson et al., 1989). Still, it is possible that a small
raction of pRB remains active in HeLa cells. Because
RB dephosphorylation would be expected to inhibit E2
ranscription by sequestering E2F into an inhibitory com-
lex, it became important to determine whether the in-
ibitory effect of E4-ORF4 on E2F-1/DP-1 transactivation
unctioned in the absence of pRB. As shown in Fig. 6,
oexpression of E4-ORF4 with E2F-1/DP-1 also resulted
n a significant reduction in E2F transactivation capacity
n SAOS-2 cells that do not express a functional pRB
Shew et al., 1990). Thus E4-ORF4 represses E2F trans-
ctivation in the absence of pRB. As expected, cotrans-
ection of pRB also repressed E2F-1/DP-1 transactiva-
ion. Interestingly, the inhibitory effect of pRB was not
ignificantly enhanced by E4-ORF4 in SAOS-2 cells. This
esult may be important because it implies that the E4-
RF4-PP2A complex does not affect the phosphorylated
tatus of pRB. In agreement with this possibility, we were
nable to detect a change in pRB phosphorylation in the
resence of E4-ORF4 (data not shown). Taken together,
ur results suggest that the inhibitory effect of E4-ORF4
n E2F transactivation works independently of pRB.
4-ORF4 inhibits E2 mRNA expression in virus-
nfected cells
To determine whether the effect of E4-ORF4 on E2
ranscription also extended to a viral infection, we com-
ared E2 mRNA expression in HeLa cells infected with
eletion mutant viruses expressing single E4 proteins
Huang and Hearing, 1989). We used H5dl366 (E42),
FIG. 4. Transactivation by a Gal4-E2F-1 fusion protein is unaffected
y the E4-ORF4 protein. Plasmids expressing fusion proteins between
he Gal4 DNA-binding domain and CR3 (Gal4-E1A CR3) or full-length
2F-1 (Gal4-E2F-1) were transfected into HeLa cells together with the
5E1BCAT reporter plasmid containing five Gal4-binding sites. In ad-
ition, empty CMV promoter control (2) or E4-ORF4-expressing (1)
lasmids were included. Shown is a representative CAT assay and the
ean values calculated from at least three experiments, with the
tandard deviations within brackets. A schematic representation of the
al4 fusion proteins is shown to the left, and the reporter plasmid is at
he bottom.5dl366-ORF3 (encoding E4-ORF3), H5dl366-ORF4 (en-
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317Ad E4-ORF4 REGULATES E2F TRANSACTIVATIONoding E4-ORF4), or a mixture of both viruses. As shown
n Fig. 7A, infection with H5dl366-ORF3 resulted in a
ignificant stimulation of E2 mRNA expression (compare
anes 1 and 2). This finding is in line with the previous
emonstration that E4-ORF3 expression is sufficient to
FIG. 5. E4-ORF4 destabilizes E2F binding to DNA. (A) Extracts from
ransfected HeLa cells were tested for DNA binding to a single-site E2F oli
12CA5), or normal rabbit serum (NRS) were included where indicated. W
ligonucleotide was included. (B) Extracts of E2F-1/DP-1 or E2F-1/DP-1 1
or 15 min, after which a 100-fold excess of unlabeled oligonucleotide w
nlabeled mutant or wild-type oligonucleotide was included before the
xperiment is shown at the bottom. Similar results were obtained in two
FIG. 6. E4-ORF4 inhibits E2F-1/DP-1-mediated transactivation in the
bsence of pRB. Levels of CAT activity in SAOS-2 cells cotransfected
ith the E2F4CAT reporter and the E2F-1/DP-1 activator plasmids were
ssayed. Where indicated, E4-ORF4 and/or pRB expression plasmids
ere included. Relative CAT activities, based on the mean value from
t least three independent experiments, are given in percentage of
2F-1/DP-1 activation (set as 100%). Error bars show the standard
eviation. The fold activation, relative to basal reporter activity, is
hown at the top. aupport an essentially wild-type infection (Bridge and
etner, 1989; Huang and Hearing, 1989). In contrast,
nfection with H5dl366-ORF4 resulted in a dramatic re-
E2F-1/DP-1, E2F-1/DP-1 1 E4-ORF4, and E2F-1/DP-1 1 E1A (pML005)
otide. Antibodies specific for E2F-1 (sc-193; Santa Cruz), HA-tagged DP-1
indicated, a 100-fold excess of mutant (mut) or wild-type (wt) unlabeled
F4 transfected HeLa cells were incubated with the single-site E2F probe
ded for increasing amounts of time. As a control, a 100-fold excess of
of extract in the last two lanes of each panel. A quantification of the
dent experiments with different batches of extracts.
FIG. 7. E4-ORF4 inhibits E2 mRNA expression during an adenovirus
nfection. (A) HeLa cells were infected with E4 mutant viruses as
escribed in the text. Infected cells were maintained in medium con-
aining ara-C to block virus DNA replication, and cytoplasmic RNA was
repared 24 h postinfection. E2A mRNA expression was assayed by
orthern (RNA) blot analysis. (B) A duplicate set of infected cells was
reated with 100 nM okadaic acid for 12 h before harvest and RNAmock,
gonucle
hen so
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318 MANNERVIK ET AL.uction in E2 mRNA accumulation (compare lanes 1 and
). Interestingly, the negative effect of E4-ORF4 on E2
xpression was dominant over the positive effect of E4-
RF3. Thus coinfection with H5dl366-ORF3 and H5dl366-
RF4 resulted in a severe impairment of E2 mRNA ex-
ression (compare lanes 2 and 4). Importantly, treatment
f mutant virus infected cells with okadaic acid nullified
he inhibitory effect of E4-ORF4 on E2 mRNA accumula-
ion (Fig. 7B).
Collectively, these results strengthen the conclusions
rawn from the transient transfection experiments by
uggesting that E4-ORF4 also functions as an inhibitory
rotein of E2 transcription during virus growth. In com-
ination with our previous results (Bondesson et al.,
996), we conclude that E4-ORF4 regulates mRNA ex-
ression from multiple viral early promoters (E1A, E1B,
2, and E4). Interestingly, the effects vary slightly on
ndividual promoters, probably reflecting the target spec-
ficity of E4-ORF4 (Bondesson et al., 1996). In a more
xtensive study, determining the effect of individual E4
roteins on E2 transcription and virus replication, Med-
halchi et al. (1997) presented evidence suggesting that
4-ORF4 inhibits E2 mRNA expression by directly reduc-
ng the rate of E2 transcription.
DISCUSSION
The E2F transcription factor is an important cell cycle
egulator, controlling the expression of genes active in
-phase (La Thangue, 1994). It is subjected to regulation
y several mechanisms. For example, binding of pRB to
2F-1, -2, or -3 and the pRB related proteins p107 and
130 to E2F-4 and -5 results in repression of transcription
Dynlacht, 1997). This interaction is controlled by phos-
horylation such that pRB phosphorylation prevents the
nteraction (Weinberg, 1995). E2F itself is subjected to a
omplex regulation with both positive and negative sig-
als brought about by phosphorylation (see introductory
aragraphs).
To further investigate the possible contribution of
hosphorylation in the control of E2F activity in the ab-
ence of pRB, we investigated the effect of the E4-ORF4
rotein on E2 transcription in HeLa and SAOS-2 cells.
4-ORF4 binds to the serine/threonine phosphatase
P2A (Kleinberger and Shenk, 1993) and activates de-
hosphorylation of specific target proteins. Thus the E4-
RF4-PP2A complex reduces junB transcription (Klein-
erger and Shenk, 1993), E1A- and cAMP-mediated in-
uction of AP-1 activity (Muller, Kleinberger, and Shenk,
992), and E1A activation of the viral E4 promoter (Bond-
sson et al., 1996). In our assay system, E4-ORF4 dra-
atically reduced E1A activation of the E2 promoter (Fig.
). The inhibition of E1A activation was reversed by
kadaic acid, suggesting that E4-ORF4-PP2A-induced
ephosphorylation of a target protein or proteins is the
ause of this effect. Because E1A activation is primarily fediated through the E2F sites in the E2 promoter (Fig.
), E4-ORF4 could affect either E2F or E1A activity. We
ave previously shown that E1A itself does not appear to
e the primary target of E4-ORF4 (Bondesson et al.,
996). We therefore favor a model in which E4-ORF4-
P2A-induced dephosphorylation reduces the activity of
2F.
Consistent with this model, E2F-1/DP-1-mediated ac-
ivation of the E2F4CAT reporter plasmid was impaired
y E4-ORF4 coexpression (Fig. 3B). The treatment of
2F-1/DP-1-transfected HeLa cells with okadaic acid
timulated transactivation, suggesting that E2F-1/DP-1
ctivity in our experimental system is positively regulated
y phosphorylation (Fig. 3B). Interestingly, the stability of
he E2F-1/DP-1 DNA complex appears to be reduced by
4-ORF4 (Fig. 5B), suggesting that phosphorylation is
mportant for stable E2F binding to DNA. Because the
ransactivation capacity of the E2F-1 activation domain
as unaffected by E4-ORF4 (Fig. 4), we suggest that the
2-fold decrease in the stability of the E2F/DNA complex
nduced by E4-ORF4 could at least in part explain the
nhibitory effect of E4-ORF4 on E2F-1-mediated transac-
ivation. An interesting experiment to be done is to de-
ermine whether okadaic acid treatment would reverse
he inhibitory effect of E4-ORF4 on E2F DNA stability.
ecause transcription reinitiation appears to be a rate-
imiting step in vivo (Ho et al., 1996), stable binding of E2F
o DNA could be important for efficient reassembly of the
reinitiation complex.
We have not been able to demonstrate a change in the
otal phosphorylated status of either E2F-1 or DP-1 in
ransfected cells (data not shown), suggesting that the
4-ORF4-PP2A complex does not cause a massive de-
hosphorylation of E2F. More likely, the E4-ORF4 -PP2A
omplex is specific, causing a dephosphorylation of one
r a few amino acids important for E2F function. How-
ver, the failure to detect a change in E2F phosphoryla-
ion raises the possibility that the effects we observe are
ndirect due to E4-ORF4 dephosphorylation of another
actor or factors involved in E2 transcription.
Altoik et al. (1997) recently showed that PPAR-induced
hosphorylation of DP-1 inhibited the transactivation ca-
acity of E2F. In this context, PP2A-induced dephosphor-
lation stimulated E2F DNA binding. We observe the
pposite effect, namely, that E4-ORF4-PP2A-induced de-
hosphorylation inactivates E2F transactivation and po-
entially DNA binding. However, it should be noted that
oth studies suggest a significance of the phosphory-
ated status of E2F for its function. The difference in
esults may arise from differences in target specificity.
hus E1A and PPAR may induce phosphorylation of dif-
erent residues in E2F, with one causing activation (E1A)
nd the other resulting in inhibition (PPAR). In both
ases, PP2A-induced dephosphorylation reverses the ef-
ects. Alternatively, there might be cell type-specific dif-
erences in E2F function because in our experimental
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319Ad E4-ORF4 REGULATES E2F TRANSACTIVATIONystem, inhibition of phosphatases by okadaic acid treat-
ent activated E2F in the absence of E4-ORF4 (Fig. 3B,
ane 3).
Recent studies have shown that E4-ORF4 can induce
poptosis (Lavoie et al., 1998; Marcellus et al., 1998;
htrichman and Kleinberger, 1998). It is therefore impor-
ant to point out that we did not detect a decrease in cell
urvival in our short-term transient transfection experi-
ents (data not shown). Furthermore, because E4-ORF4
ad little effect on E4-ORF6/7 transactivation of the E2
romoter (Fig. 1) and Gal4-E2F-1 transactivation of the
5E1BCAT reporter plasmid (Fig. 4) it appears unlikely
hat the effects that we observe are due to E4-ORF4-
nduced apoptosis. In fact, E4-ORF4 slightly activates
asal transcription from the E2 promoter (Fig. 1). The
nhibition of E1A and E2F transactivation by E4-ORF4
herefore is probably not caused simply by cell death
nder our experimental conditions.
Previous data have shown that phosphorylation of pRB
s important to relieve its inhibitory effect on E2F tran-
cription factor activity. Here we present data suggesting
hat phosphorylation also is important in E1A activation
f the E2 promoter as well as E2F transactivation in the
bsence of pRB. Collectively, our data suggest that the
iral E4-ORF4 protein regulates E2 promoter activity by
ontrolling the phosphorylated status of E2F or a down-
tream target. In agreement with this, E2 expression is
educed by E4-ORF4 during lytic virus growth (Fig. 7)
Medghalchi et al., 1997).
MATERIALS AND METHODS
lasmid DNA
pML005 (which expresses E1A) contains nucleotides
–1773 of the adenovirus type 2 genome (Bondesson et
l., 1994). pMLDE1A is a derivative of pML005 that lacks
ost of the E1A coding sequence, except for the 18
mino-terminal amino acids. These plasmids were kindly
rovided by Dr. Catharina Svensson. pCMVDP-1 (Helin et
l., 1993) (containing an HA epitope tag), pCMVE2F-1
Helin et al., 1993), pSGRB (kindly provided by W. G.
aelin), the E4-ORF4- and E4-ORF6/7-expressing plas-
ids, and the CMV promoter backbone plasmid (Ohman
t al., 1993) have all been described previously. Gal-
2F-1 was constructed by transfer of the E2F-1 coding
equence into the pSG424 plasmid (encoding Gal4 (1–
47) (Sadowski et al., 1988). Gal-CDoff (here designated
al-E1A CR3) has been described previously (Bondes-
on et al., 1994). The reporter plasmids E2CAT (p2CAT in
eeks and Jones, 1983), E2(2ATF)CAT, E2(2E2F)CAT
referred to as pE2(280/70)CAT and pE2(264/60, 245/
6)CAT in Loeken and Brady, 1989], E2F4CAT (Helin et
l., 1993), and G5E1BCAT (Lillie and Green, 1989) have all
een described previously. Wransfection and reporter gene analysis
Subconfluent HeLa monolayer cells were grown and
ransfected according to the calcium phosphate copre-
ipitation technique as described previously (Bondesson
t al., 1996). Transfections were supplemented with ei-
her pUC19 or salmon sperm DNA up to a total of 12–15 mg
f DNA/60-mm dish. In Figs. 1 and 2 5 mg of E2CAT
eporter plasmid or its derivatives E2(2ATF)CAT and
2(2E2F)CAT was transfected together with 2 mg of
1A-expressing plasmid and 1 mg of empty CMV vector
r E4-expressing plasmids. In Fig. 3 100 ng of
CMVE2F-1 and 100 ng of pCMVDP-1 were cotrans-
ected with 3 mg of E2F4CAT reporter. Where indicated, 2
g of E1A-expressing plasmid and/or 1 mg of CMV pro-
oter or E4-ORF4 expression plasmids was included. In
ig. 4 3 mg of the G5E1BCAT reporter was transfected
ogether with 200 ng of Gal4-E1A CR3 or 500 ng of
al4-E2F-1 and 1 mg of CMV promoter or E4-ORF4-
xpressing plasmids. Where indicated, the cells were
reated with 100 nM okadaic acid (Boehringer) for ;12 h
efore harvesting. Cell extracts were prepared by freeze-
hawing. The protein concentration was determined ac-
ording to the Bradford method (Ausubel et al., 1987),
nd extracts equalized for protein concentration were
ssayed for CAT activity as described previously (Bond-
sson et al., 1996).
Subconfluent SAOS-2 cells were grown on 35-mm
etri dishes and transfected using the FuGENE 6 trans-
ection reagent (Boehringer). Here 1 mg of E2F4CAT
eporter plasmid was cotransfected with 0.1 mg of
CMVE2F-1 and pCMVDP-1 together with 1.0 mg of the
4-ORF4 expression plasmid. An empty CMV expression
lasmid was used as a control to give an equal amount
f CMV promoter-containing plasmids in each transfec-
ion. Where indicated, 0.5 mg of a pSGRB was included.
t 48 h posttransfection, the cells were lysed and ana-
yzed as described above. All experiments were per-
ormed at least three times. Quantitative results were
btained with PhosphorImager (Bio-Rad) scanning.
el retardation assays
Gel retardation assays were performed essentially as
escribed previously (Helin and Harlow, 1994). HeLa
ells grown on 10-cm tissue culture plates were trans-
ected with 8 mg of pCMVE2F-1 and pCMVDP-1 plas-
ids, 4 mg of empty CMV vector, E4-ORF4 or E1A ex-
ression plasmids, and whole-cell extracts prepared as
escribed by Helin and Harlow (1994). Then 5-mg por-
ions of extract were added to a 10-ml mix consisting of
inding buffer (Helin and Harlow, 1994), 2 mg of soni-
ated salmon sperm DNA, 5% glycerol, and 0.3 ng of a
9-32P-end-labeled probe and incubated for 30 min at
oom temperature. The samples were run on a 4% poly-
crylamide gel in 0.253 TEB at 4°C and 180 V for 2–3 h.
here indicated, a 100-fold excess of wild-type or mutant
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320 MANNERVIK ET AL.ligonucleotide was added before the extract. Then 1 ml
f antibody specific for E2F-1 (sc-193; Santa Cruz), the
A epitope tag in DP-1 (12CA5), or normal rabbit serum
as added after 15 min of preincubation when so indi-
ated.
In the off-rate experiment, extract was incubated with
robe for 15 min at room temperature, after which a
00-fold excess of cold wild-type oligonucleotide was
dded, and incubation continued for the indicated
mount of time (Fig. 5B).
The wild-type and mutant oligonucleotides containing
single E2F site have been described (Helin et al., 1992).
irus infection and RNA blot analysis
Subconfluent monolayers of HeLa cells were grown on
-cm plates and infected at a multiplicity of 100 fluores-
ence-forming units (FFU)/cell with the following combi-
ations of E4 mutant viruses (Huang and Hearing, 1989):
ane 1, 100 FFU H5dl366; lane 2, 50 FFU H5dl366-ORF3
lus 50 FFU H5dl366; lane 3, 50 FFU H5dl366-ORF4 plus
0 FFU H5dl366; lane 4, 50 FFU H5dl366-ORF3 plus 50
FU H5dl366-ORF4; and lane 5, mock infected. At the
ime of infection, 1-b-D-arabinofuranosylcytosine (ara-C)
as added at a concentration of 20 mg/ml, and an addi-
ional 20 mg/ml ara-C was added every 8 h. The infec-
ions shown in Fig. 7B also contained 100 nM okadaic
cid that was added 12 h postinfection. Total cytoplasmic
NA was prepared 24 h postinfection by IsoB/Nonidet
-40 treatment and phenol–chloroform extraction (Svens-
on and Akusja¨rvi, 1984). Five micrograms of cytoplas-
ic RNA from each infection was electrophoresed in a
% agarose gel containing 1.8% formaldehyde, trans-
erred to a nylon filter, and hybridized to a 32P-labeled E2
robe (Ad2 bp 23304–24890; detecting the gene for the
2A 72K-DBP) at 42°C for 18 h. The hybridization solution
ontained 50% formamide, 53 Denhardt9s solution, 53
SC, 10% dextran sulfate, and 1% SDS. After hybridiza-
ion, the filter was washed 2 times for 15 min at room
emperature in 23 SSC before autoradiography.
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